144 related articles for article (PubMed ID: 20138250)
1. [Neurofibromatosis type 2].
Pérez-Grau M; Miró N; Prades J; Vergés J; Lareo S; Roca-Ribas F
Acta Otorrinolaringol Esp; 2010; 61(4):306-11. PubMed ID: 20138250
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis type 2.
Evans DG; Sainio M; Baser ME
J Med Genet; 2000 Dec; 37(12):897-904. PubMed ID: 11106352
[TBL] [Abstract][Full Text] [Related]
3. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
[TBL] [Abstract][Full Text] [Related]
4. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
Kley N; Whaley J; Seizinger BR
Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
[TBL] [Abstract][Full Text] [Related]
6. Neurofibromatosis type 2 (NF2): diagnosis and management.
Lloyd SK; Evans DG
Handb Clin Neurol; 2013; 115():957-67. PubMed ID: 23931824
[TBL] [Abstract][Full Text] [Related]
7. Preservation of auditory and vestibular function after surgical removal of bilateral vestibular schwannomas in a patient with neurofibromatosis type 2.
Black FO; Brackmann DE; Hitselberger WE; Purdy J
Am J Otol; 1995 Jul; 16(4):431-43. PubMed ID: 8588642
[TBL] [Abstract][Full Text] [Related]
8. Management strategies in neurofibromatosis type 2.
Moffat DA; Quaranta N; Baguley DM; Hardy DG; Chang P
Eur Arch Otorhinolaryngol; 2003 Jan; 260(1):12-8. PubMed ID: 12520350
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis 2--a family journey.
Clarke L
Can J Neurosci Nurs; 2009; 31(4):7-14. PubMed ID: 20085115
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas.
Sirén V; Antinheimo JP; Jääskeläinen J; Böhling T; Carpén O; Vaheri A
Acta Neurochir (Wien); 2004 Feb; 146(2):111-8. PubMed ID: 14963743
[TBL] [Abstract][Full Text] [Related]
11. Neurofibromatosis type 2 (NF2): a clinical and molecular review.
Evans DG
Orphanet J Rare Dis; 2009 Jun; 4():16. PubMed ID: 19545378
[TBL] [Abstract][Full Text] [Related]
12. Vestibular schwannoma: role of conservative management.
Suryanarayanan R; Ramsden RT; Saeed SR; Aggarwal R; King AT; Rutherford SA; Evans DG; Gillespie JE
J Laryngol Otol; 2010 Mar; 124(3):251-7. PubMed ID: 20003606
[TBL] [Abstract][Full Text] [Related]
13. Multiple meningiomas: differential involvement of the NF2 gene in children and adults.
Evans DG; Watson C; King A; Wallace AJ; Baser ME
J Med Genet; 2005 Jan; 42(1):45-8. PubMed ID: 15635074
[TBL] [Abstract][Full Text] [Related]
14. Outcome from surgery for vestibular schwannomas in children.
MacNally SP; Rutherford SA; King AT; Freeman S; Thorne J; Mawman D; O'Driscoll MP; Evans DG; Ramsden RT
Br J Neurosurg; 2009 Jun; 23(3):226-31. PubMed ID: 19533454
[TBL] [Abstract][Full Text] [Related]
15. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
[TBL] [Abstract][Full Text] [Related]
16. Laryngeal plexiform schwannoma as first symptom in a patient with neurofibromatosis type 2.
Nagato T; Katada A; Yoshizaki T; Kunibe I; Takahara M; Katayama A; Hayashi T; Harabuchi Y
Clin Neurol Neurosurg; 2010 Jul; 112(6):505-8. PubMed ID: 20303213
[TBL] [Abstract][Full Text] [Related]
17. Further genotype--phenotype correlations in neurofibromatosis 2.
Selvanathan SK; Shenton A; Ferner R; Wallace AJ; Huson SM; Ramsden RT; Evans DG
Clin Genet; 2010 Feb; 77(2):163-70. PubMed ID: 19968670
[TBL] [Abstract][Full Text] [Related]
18. Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up.
Neff BA; Wiet RM; Lasak JM; Cohen NL; Pillsbury HC; Ramsden RT; Welling DB
Laryngoscope; 2007 Jun; 117(6):1069-72. PubMed ID: 17545869
[TBL] [Abstract][Full Text] [Related]
19. Neurofibromatosis type 2: genetic and clinical features.
Evans DG
Ear Nose Throat J; 1999 Feb; 78(2):97-100. PubMed ID: 10089694
[TBL] [Abstract][Full Text] [Related]
20. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]